DATASET

EURL ECVAM indicators to assess the impact of EU-funded research into Alzheimer's Disease, Breast Cancer and Prostate Cancer

Collection: EURL-ECVAM : European Union Reference Laboratory for Alternatives to Animal Testing 

Description

Biomedical research is extremely resource intensive. Therefore, monitoring its outputs and impacts can be considered a priority to gain an understanding of the most productive research avenues worth investing in.

For this reason, in 2019 the European Commission’s Joint Research Centre (JRC), through its European Union Reference Laboratory for alternatives to animal testing (EURL ECVAM), initiated a project to define suitable and reliable indicators to measure the innovation and impact of EU-funded research in three areas of biomedical research: Alzheimer’s disease, breast cancer and prostate cancer. These diseases are highly prevalent, representing a heavy societal and economic burden for Europe, and have attracted a large share of the investments made through several Commission funding programmes.

A set of 14 indicators was built that cover different scientific and societal aspects. This dataset provides the main data used to select, refine and implement these indicators as described in the JRC report "Building indicators to assess the impact of EU-funded research into Alzheimer's disease, Brest cancer and Prostate cancer". This dataset can also be used to generate additional indicators and insight through an integrated analysis applied to the abovementioned biomedical research areas.

Contact

Email
jrc-f3-enquiries (at) ec.europa.eu

Contributors

  • Annalisa Gastaldello
  • Pierre Deceuninck

How to cite

Annalisa Gastaldello; Deceuninck, Pierre (2023): EURL ECVAM indicators to assess the impact of EU-funded research into Alzheimer's Disease, Breast Cancer and Prostate Cancer. European Commission, Joint Research Centre (JRC) [Dataset] PID: http://data.europa.eu/89h/a96ad0dd-f23a-4ee4-a839-04928c1c5cf3

Keywords

Alzheimer's disease Biomedical research Breast cancer EU Projects Prostate cancer

Data access

EU-funded research in three areas of biomedical research: Alzheimer’s disease, breast cancer and prostate cancer. Indicator building data.
Download 
  • This dataset provides the main data used to select, refine and implement these indicators as described in the JRC report "Building indicators to assess the impact of EU-funded research into Alzheimer's disease, Brest cancer and Prostate cancer". This dataset can also be used to generate additinal indicators and insight through an integrated analysis applied to the abovementioned biomedical research areas.

Publications

Publication 2023
Building indicators to assess the impact of EU-funded research into Alzheimer's disease, breast cancer and prostate cancer
Gastaldello, A., Bernasconi, C., Campia, I., Daskalopoulos, E., Deceuninck, P., Pistollato, F. and Whelan, M., Building indicators to assess the impact of EU-funded research into Alzheimer`s disease, breast cancer and prostate cancer, EUR 31435 EN, Publications Office of the European Union, Luxembourg, 2023, ISBN 978-92-68-00311-4 (online), doi:10.2760/63620 (online), JRC132705.
  • Publications Office of the European Union, Luxembourg, Luxembourg
Publication page 
  • Abstract

    Biomedical research is extremely resource intensive, thus monitoring its outputs and impacts can be considered a priority to gain an understanding of the most productive research avenues worth investing in. For this reason, in 2019 the Joint Research Centre (JRC) of the EC through the European Union Reference Laboratory for Alternatives to Animal Testing (EURL- ECVAM) initiated a project aiming to define suitable and reliable indicators to assess the contribution to innovation and the impact of EU-funded research into three biomedical research areas: Alzheimer’s disease (AD), breast cancer (BC) and prostate cancer (PC). Such diseases are of high prevalence, representing a heavy societal and economic burden for Europe, and have attracted a big share of the investments made through several EC funding programmes. A set of fourteen indicators was built, covering different scientific and societal aspects. This report provides details on the methodology used to select, refine and implement these indicators, and also gives an overview of the type of knowledge they can generate through an integrated analysis applied to the abovementioned biomedical research areas. Lastly, a quality assessment of these indicators highlights their strengths and weaknesses to allow a transparent use of the information contained within them.

Geographic areas

European Union

Temporal coverage

From date To date
1999-01-01 2019-12-31

Additional information

Published by
European Commission, Joint Research Centre
Created date
2023-03-31
Modified date
2023-05-02
Issued date
2023-05-02
Landing page
https://joint-research-centre.ec.europa.eu/eu-reference-laboratory-alternatives-animal-testing-eurl-ecvam_en 
Language(s)
English
Data theme(s)
Economy and finance, Health, Science and technology
Update frequency
irregular
Identifier
http://data.europa.eu/89h/a96ad0dd-f23a-4ee4-a839-04928c1c5cf3
Popularity